Executive Summary
The April 27, 2026, filings highlight the onset of Q4/FY26 earnings season with board meetings scheduled for IDBI Bank (Apr 30), Tata Motors (May 13), and results already approved for Bondada Engineering (unmodified audit), signaling clean financial closes amid neutral sentiment. Infosys reported FY26 revenue growth of 3.1% YoY CC (Q4 +4.1%) driven by $14.9B large deals (+28% YoY) and AI services >5.5% of revenue, but FY27 guidance is muted at 1.5-3.5% amid competition and productivity drags, with margins guided 20-22% (FY26 at 21%). Mahindra & Mahindra's acquisition of 28.03% in Carnot Technologies (rev decline to Rs.19.8cr FY26 from Rs.23.08cr FY25/-14%, Rs.24.81cr FY24/-20%) boosts stake to 80.72%, while Apollo Hospitals advances NCLT-approved scheme with meetings May 21-27. Shree Renuka faces Rs.1.52cr penalty (FY18-22 ITC issues, appealed, no material impact), and MRPL's JV with ONGC/OPaL (25% stake, Rs.12.5cr equity) eyes petrochemical synergies. Portfolio trends show revenue deceleration in subs (Carnot -14% YoY) and IT (+3% vs historical highs), with positive catalysts in healthcare schemes and energy JVs offsetting minor regulatory penalties.
Tracking the trend? Catch up on the prior India SEBI Regulatory Enforcement Actions digest from April 20, 2026.
Investment Signals(12)
- Shree Renuka Sugars↓(BEARISH)▲
Penalty Rs.1.52cr on ITC non-reversal FY18-22, but appealed with strong merit claim and no material financial/ops impact
- Mahindra & Mahindra↓(BULLISH)▲
Acquired 28.03% in Carnot for Rs.6.72cr at Rs.11,978/share, lifting stake to 80.72% equity/89% voting amid precision farming push, despite Carnot rev decline 14% YoY FY26
- Apollo Hospitals↓(BULLISH)▲
NCLT approves dispensation of secured creditors' meeting (90.96% consent), reschedules equity/unsecured meetings May 21-27 for scheme with Apollo Healthco/Keimed/Healthtech
- Tata Motors↓(NEUTRAL-BULLISH)▲
Board meeting May 13 for Q4/FY26 audited results and dividend recommendation, trading window closed since Mar 25, analyst call same day
- Infosys↓(MIXED-BEARISH)▲
FY26 rev +3.1% YoY CC (Q4 +4.1%), large deals $14.9B (+28% YoY), AI rev >5.5% (up from Q3), but FY27 guidance 1.5-3.5% CC with 20-22% margins amid competition
- Bondada Engineering↓(BULLISH)▲
Q4/FY26 audited standalone/consolidated results approved with unmodified auditor opinion (M/s. Sreedar Mohan), full disclosure on website
- IDBI Bank↓(NEUTRAL)▲
Board meeting Apr 30 for Q4/FY26 audited results, trading window closed till May 2
- Mangalore Refinery (MRPL)(BULLISH)▲
ONGC board approves petrochemicals JV (50:25:25 ONGC/MRPL/OPaL), MRPL Rs.12.5cr equity for synergies in marketing/pricing/logistics
- Infosys↓(BEARISH)▲
Employee count down >8,000 in 5-6 quarters, margins resilient at 21% FY26 despite 1% drag from third-party rev and 70bps on-site mix
- Mahindra & Mahindra↓(BEARISH)▲
Carnot FY26 PAT Rs.1.17cr, net worth Rs.6cr on declining rev trajectory (FY25 Rs.23.08cr, FY24 Rs.24.81cr)
- Apollo Hospitals↓(BULLISH)▲
Scheme progression under Sections 230-232, NCLT modifies dates avoiding prior secured meeting
- Bondada Engineering↓(BULLISH)▲
Board meeting Apr 27 (6:30-8:45 PM) confirms clean audit, no qualifications
Risk Flags(10)
- Shree Renuka Sugars/Regulatory↓[HIGH RISK]▼
Rs.1.52cr penalty (2 orders Dec 4, 2025) for ITC non-reversal on damaged goods/excess blocked credits FY18-22, disclosure delay condonation sought
- Mahindra & Mahindra/Subsidiary Performance↓[MEDIUM RISK]▼
Carnot rev declined 14% YoY FY26 (Rs.19.8cr vs Rs.23.08cr FY25) and 20% vs FY24 (Rs.24.81cr), related party acquisition at Rs.11,978/share
- Infosys/Guidance↓[HIGH RISK]▼
FY27 rev guidance 1.5-3.5% YoY CC (down from FY26 3.1%), competitive intensity, AI productivity, client spending compression; employee decline >8,000 in 5-6 qtrs
- Infosys/Margins↓[MEDIUM RISK]▼
FY26 margins 21% resilient but Q4 headwinds 50bps acquisition amortization, 20bps comp, despite offsets; FY27 20-22% guided
- Shree Renuka Sugars/Disclosure↓[LOW-MEDIUM RISK]▼
Unintentional delay in SEBI Reg 30 intimation on penalties
- Mahindra & Mahindra/Transaction↓[LOW RISK]▼
Related party deal completion May 2026, potential scrutiny on arm's length pricing
- Infosys/Acquisitions↓[MEDIUM RISK]▼
Stratus closed (+25bps FY27), Optimum/Aus JV pending regs, not in guidance
- Tata Motors/Trading Window↓[LOW RISK]▼
Closed since Mar 25 till 48hrs post-results, no insider activity noted
- IDBI Bank/Trading Window↓[LOW RISK]▼
Closed till May 2 for results, compliance with PIT regs
- MRPL/JV[MEDIUM RISK]▼
Rs.12.5cr equity commitment pending DIPAM approval
Opportunities(10)
- Apollo Hospitals/NCLT Scheme↓(OPPORTUNITY)◆
90.96% secured creditor consent dispenses meeting, equity mtg May 27, unsecured May 21/26; progresses Apollo Healthco/Keimed/Healthtech integration
- Bondada Engineering/Earnings↓(OPPORTUNITY)◆
Clean unmodified audit on Q4/FY26 results, full disclosure imminent on website; potential beat on engineering sector trends
- Tata Motors/Earnings Catalyst↓(OPPORTUNITY)◆
May 13 board for audited FY26 results/dividend, analyst call same day; watch auto sector recovery post trading window
- IDBI Bank/Earnings Catalyst↓(OPPORTUNITY)◆
Apr 30 board for FY26 results; early banking readout amid sector deposit/NIM focus
- MRPL/Petrochem JV(OPPORTUNITY)◆
25% stake in ONGC-led JV for marketing synergies, cost reduction, third-party sales; Rs.12.5cr equity post-DIPAM
- Infosys/Large Deals↓(OPPORTUNITY)◆
$14.9B TCV FY26 (+28% YoY), Q4 $3.2B; AI >5.5% rev despite modest guidance
- Mahindra & Mahindra/Strategic Stake↓(OPPORTUNITY)◆
80.72% equity/89% voting in Carnot (telematics/precision farming), aligns with M&M tech strategy
- Infosys/AI Growth↓(OPPORTUNITY)◆
AI services >5.5% Q4 rev (up QoQ), margin offsets via currency (+40bps Q4)
- Apollo Hospitals/Meeting Timeline↓(OPPORTUNITY)◆
Secured mtg May 27 10AM, equity 2:30PM; fast-track to scheme approval
- Bondada Engineering/Clean Audit↓(OPPORTUNITY)◆
No qualifications from M/s. Sreedar Mohan, positions for dividend/reinvestment signals
Sector Themes(6)
- Earnings Season Kickoff (Auto/Banking/Engineering)◆
4/8 filings (Tata Motors May13, IDBI Apr30, Bondada approved, Infosys reported) signal Q4/FY26 results wave; clean audits (Bondada unmodified) vs pending (others), watch dividend recos (Tata) for capital returns amid trading windows closed 1-2 months
- IT Services Growth Moderation◆
Infosys FY26 +3.1% YoY CC (Q4 +4.1%) with $14.9B deals (+28%) but FY27 1.5-3.5% guided lower; employee cuts >8k/5-6qtrs, AI >5.5% offset by competition/productivity, margins steady 20-22%
- Healthcare Scheme Progress◆
Apollo NCLT fast-tracks with 90.96% consent, May 21-27 meetings; implies reduced execution risk in consolidations (Healthco/Keimed/Healthtech) vs historical delays
- Energy/Subsidiary Declines & Synergies◆
MRPL JV (25% petrochemicals marketing) for cost/rev synergies; parallels M&M Carnot rev -14% YoY but strategic stake hike to 89% voting
- Regulatory Penalties Minor◆
1/8 (Renuka Rs.1.52cr appealed, no impact) vs positives (NCLT/JV); sugars/ITC issues isolated, disclosures delayed but condoned
- Capital Allocation Pending◆
Dividend considers (Tata), equity infusions (M&M Rs.6.72cr, MRPL Rs.12.5cr), no buybacks/splits; focus shifting to results for ROE/debt trends
Watch List(8)
Apr 30 FY26 results approval; monitor NIM/deposit trends, trading window till May 2 [Apr 30, 2026]
May 13 for audited FY26 results/dividend; analyst call same day, window reopens 48hrs post [May 13, 2026]
May 27 2:30PM for scheme approval; track voting outcomes post 90.96% creditor consent [May 27, 2026]
Mtgs May 21 (11AM Co1), May 26 (3PM Co3); venue risks/dispensations [May 21/26, 2026]
Guidance 1.5-3.5% CC, watch Q1 updates on AI (>5.5%), acquisitions (Optimum/JV pending), employee trends [Ongoing Q1 FY27]
Carnot deal completion May 2026; post-rev decline scrutiny on integration [May 2026]
- MRPL/JV Approval👁
DIPAM nod for Rs.12.5cr equity in ONGC JV; petrochemical synergies timeline [Pending DIPAM]
CGST penalty Rs.1.52cr appeals; material impact confirmation [TBD post-appeal]
Filing Analyses(8)
27-04-2026
Shree Renuka Sugars Limited received two penalty orders dated December 4, 2025, from the Assistant Commissioner of CGST & Central Excise, Belagavi City Division, totaling ₹1,52,27,920 for alleged non-reversal of Input Tax Credit on damaged goods and excess ITC on blocked credits during FY 2018-2022. The company maintains a bona-fide view of strong merit, has filed appeals, and asserts no material impact on financials or operations beyond the penalty amount itself. The intimation under SEBI Regulation 30 was filed on April 27, 2026, citing an unintentional delay.
- ·NSE Symbol: RENUKA; BSE Scrip Code: 532670
- ·Corporate Identification No.: L01542KA1995PLC019046
- ·Delay in disclosure due to inadvertent omission, requesting condonation
27-04-2026
Mahindra & Mahindra Ltd has acquired an additional 28.03% stake in its subsidiary Carnot Technologies Private Limited for Rs. 6.72 crore, increasing its equity holding to 80.72% and voting rights to 89%, aligning with its strategy in precision farming and telematics. Carnot reported FY26 revenue of Rs. 19.80 crore, marking a decline from Rs. 23.08 crore in FY25 and Rs. 24.81 crore in FY24, alongside PAT of Rs. 1.17 crore and net worth of Rs. 6.00 crore. The transaction is a related party deal on arm's length basis, with completion expected in May 2026.
- ·Share purchase price: Rs.11,978 per share
- ·Carnot date of incorporation: 24th August 2015
- ·Transaction executed on April 27, 2026 at 06:11 p.m., indicative completion: May 2026
- ·No governmental or regulatory approvals required
27-04-2026
Apollo Hospitals Enterprise Limited received the certified true copy of the NCLT Chennai order dated April 15, 2026, on April 27, 2026, approving dispensation of the secured creditors' meeting for the composite scheme of arrangement due to 90.96% consent via affidavit, avoiding the previously ordered meeting. The order also modifies and approves new dates for equity shareholders' meeting (27th May 2026, 2:30 PM), unsecured creditors' meetings (21st May 2026, 11:00 AM for Company 1; 26th May 2026, 3:00 PM for Company 3 at specified venue), and secured creditors' meeting (27th May 2026, 10:00 AM). This progresses the scheme involving Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited under Sections 230-232 of the Companies Act, 2013.
- ·NCLT application numbers: CA/CAA/8/CHE/2026, IA(CA)/99/CHE/2026, IA(CA)/100/CHE/2026, IA(CA)/101/CHE/2026
- ·Original meeting dates modified from 16th May 2026 and 17th May 2026
- ·Unsecured creditors meeting for Company 3 at Paragon Towers, Plot No. 9 & 10, Rukmani Colony, Nehru Nagar, 1st Street, Kottivakkam, Chennai
27-04-2026
Tata Motors Limited has scheduled a Board of Directors meeting on May 13, 2026, to consider and approve the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026, along with auditors' reports. The board will also recommend a dividend declaration, if any, for shareholder approval at the forthcoming 2nd Annual General Meeting. The trading window for designated persons remains closed from March 25, 2026, until 48 hours after the financial results publication, with an analyst/investors' call planned on the announcement day.
- ·Trading Window closure: March 25, 2026, to 48 hours post-publication of financial results.
- ·Analyst/Investors’ call to be hosted on www.cv.tatamotors.com on the day of financial results announcement.
- ·Intimation under Regulations 29(1)(a), 50(1)(c), and 30 of SEBI Listing Regulations.
27-04-2026
Infosys delivered FY26 revenue growth of 3.1% in constant currency terms, with Q4 growth at 4.1% YoY CC, supported by strong performance in Financial Services, Communications, Manufacturing, and Europe, alongside large deals of $14.9B for the year (28% YoY increase) and $3.2B in Q4. AI services revenue grew beyond 5.5% of total revenue in Q4 from Q3 levels. However, FY27 revenue guidance is modest at 1.5% to 3.5% YoY CC amid competitive intensity, AI productivity impacts, and client spending compression, with operating margins guided at 20% to 22%; FY26 margins were resilient at 21% despite headwinds like 1% drag from lower third-party revenue and 70 bps from on-site mix.
- ·Employee count declined by over 8,000 in the last five to six quarters.
- ·Stratus acquisition closed and contributes 25 basis points to FY27 guidance; Optimum and Australian JV pending regulatory approvals, not yet included.
- ·Q4 margin headwinds: 50 bps from acquisition amortization, 20 bps from comp, partially offset by 40 bps currency benefit and 30 bps from Maximus.
- ·AI total addressable market estimated at $300-400B by 2030.
- ·Net new large deals at 55% for FY26.
27-04-2026
The Board of Directors of Bondada Engineering Limited met on April 27, 2026, and approved the Audited Standalone and Consolidated Financial Results for Q4 FY 2025-26 and the full financial year ended March 31, 2026. The statutory auditors, M/s. Sreedar Mohan & Associates, issued an unmodified opinion on both standalone and consolidated results. The disclosures will be available on the company's website at www.bondada.net.
- ·Board meeting held from 06:30 PM to 08:45 PM at C-26, Kushaiguda Industrial Area, ECIL, Hyderabad, Telangana 500062.
- ·CIN: L28910TG2012PLC080018
- ·Scrip Code: 543971
27-04-2026
IDBI Bank Limited announced that a Board of Directors meeting will be held on April 30, 2026, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2026, in compliance with SEBI (LODR) Regulations. The Trading Window for dealing in the Bank's securities by designated persons and their immediate relatives will remain closed until May 02, 2026, per the Bank's Code of Conduct and SEBI (Prohibition of Insider Trading) Regulations.
- ·Filing reference to Regulations 29 and 50 of SEBI (LODR) Regulations, 2015.
- ·Regd. Office: IDBI Tower, WTC Complex, Cuffe Parade, Mumbai - 400 005.
- ·CIN: L65190MH2004G01148838.
27-04-2026
Mangalore Refinery and Petrochemicals Limited (MRPL) discloses that the Board of Directors of its holding company ONGC has approved the formation of an Integrated Petrochemicals Marketing & Trading Joint Venture Company with shareholding ratios of 50:25:25 by ONGC, MRPL, and OPaL respectively. MRPL will contribute ₹12.5 Cr towards the equity share capital of the JV, subject to approval from the Department of Investment and Public Asset Management (DIPAM), Ministry of Finance, Govt. of India. The JV aims to integrate petrochemicals marketing of group companies, achieve synergies to reduce costs and increase revenue through improved pricing, logistics, and production of speciality grades, and enable third-party sales.
- ·Shareholding ratio in JV: 50% ONGC, 25% MRPL, 25% OPaL
- ·Approval pending from Department of Investment and Public Asset Management (DIPAM), Ministry of Finance, Govt. of India
- ·Communication received from ONGC on 27/04/2026
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 8 filings
More from: India SEBI Regulatory Enforcement Actions
🇮🇳 More from India
View all →April 20, 2026
India Pre-Market Regulatory Roundup — April 20, 2026
India Pre-Market Regulatory Roundup
April 20, 2026
India Quarterly Results BSE NSE Announcements — April 20, 2026
India Quarterly Results BSE NSE Announcements
April 20, 2026
India Upcoming Corporate Actions BSE NSE — April 20, 2026
India Upcoming Corporate Actions BSE NSE
April 20, 2026
BSE FMCG Sector Regulatory Filings — April 20, 2026
BSE FMCG Sector Regulatory Filings